The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Open accessAbstract
Doxorubicin (DOX) constitutes the major constituent of anti-cancer treatment regimens currently in clinical use. However, the precise mechanisms of DOX’s action are not fully understood. Emerging evidence points to the pleiotropic anticancer activity of DOX, including its contribution to DNA damage, reactive oxygen species (ROS) production, apoptosis, senescence, autophagy, ferroptosis, and pyroptosis induction, as well as its immunomodulatory role. This review aims to collect information on the anticancer mechanisms of DOX as well as its influence on anti-tumor immune response, providing a rationale behind the importance of DOX in modern cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
Zorov, D. B., Juhaszova, M., & Sollott, S. J. (2014) · Physiological Reviews · doi:10.1152/physrev.00026.2013 · Cited by 5,383
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
Activation of apoptosis signalling pathways by reactive oxygen species
Redza-Dutordoir, M., & Averill-Bates, D. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.09.012 · Cited by 3,731
Liposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,632
Role of reactive oxygen species (ROS) in apoptosis induction
Simon, H.-U., Haj-Yehia, A., & Levi-Schaffer, F. (2000) · Apoptosis · doi:10.1023/a:1009616228304 · Cited by 2,774
Hallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Tacar, O., Sriamornsak, P., & Dass, C. R. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01567.x · Cited by 2,465
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Pommier, Y., Leo, E., Zhang, H., & Marchand, C. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.04.012 · Cited by 1,829
ATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
Mathew, R., Karantza-Wadsworth, V., & White, E. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2254 · Cited by 1,798
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Bukowski, K., Kciuk, M., & Kontek, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093233 · Cited by 1,757
Self-citationDoxorubicin pathways: pharmacodynamics and adverse effects
Thorn, C. F., Oshiro, C., Marsh, S., Hernandez-Boussard, T., McLeod, H., Klein, T. E., & Altman, R. B. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833ffb56 · Cited by 1,648
Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., & Liu, L. F. (1984) · Science · doi:10.1126/science.6093249 · Cited by 1,538
Immunological effects of conventional chemotherapy and targeted anticancer agents
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.012 · Cited by 1,530
DNA Damage Sensing by the ATM and ATR Kinases
Marechal, A., & Zou, L. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012716 · Cited by 1,514
Doxorubicin: The good, the bad and the ugly effect
Carvalho, C., Santos, R., Cardoso, S., Correia, S., Oliveira, P., Santos, M., & Moreira, P. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788803312 · Cited by 1,509
Cdks, cyclins and CKIs: roles beyond cell cycle regulation
Lim, S., & Kaldis, P. (2013) · Development · doi:10.1242/dev.091744 · Cited by 1,487
Liu, P., Chen, G., & Zhang, J. (2022) · Molecules · doi:10.3390/molecules27041372 · Cited by 1,334
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324
ATM Activation by Oxidative Stress
Guo, Z., Kozlov, S., Lavin, M. F., Person, M. D., & Paull, T. T. (2010) · Science · doi:10.1126/science.1192912 · Cited by 1,079
ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age‐Related Diseases
Davalli, P., Mitic, T., Caporali, A., Lauriola, A., & D’Arca, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3565127 · Cited by 1,059
Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111708 · Cited by 909
Voorwerk, L., Slagter, M., Horlings, H. M., Sikorska, K., van de Vijver, K. K., de Maaker, M., Nederlof, I., Kluin, R. J. C., Warren, S., Ong, S., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0432-4 · Cited by 905
The role of pyroptosis in cancer: pro-cancer or pro-“host”?
Xia, X., Wang, X., Cheng, Z., Qin, W., Lei, L., Jiang, J., & Hu, J. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1883-8 · Cited by 856
The essential kinase ATR: ensuring faithful duplication of a challenging genome
Saldivar, J. C., Cortez, D., & Cimprich, K. A. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.67 · Cited by 838
García-Ruiz, C., Colell, A., Marí, M., Morales, A., & Fernández-Checa, J. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11369 · Cited by 806
DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
Sato, H., Niimi, A., Yasuhara, T., Permata, T. B. M., Hagiwara, Y., Isono, M., Nuryadi, E., Sekine, R., Oike, T., Kakoti, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01883-9 · Cited by 702
Doxorubicin, DNA torsion, and chromatin dynamics
Yang, F., Teves, S. S., Kemp, C. J., & Henikoff, S. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.12.002 · Cited by 695
Doxorubicin cardiotoxicity: analysis of prevailing hypotheses
Olson, R. D., & Mushlin, P. S. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.13.2210154 · Cited by 690
Regulated cell death pathways in doxorubicin-induced cardiotoxicity
Christidi, E., & Brunham, L. R. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03614-x · Cited by 684
(2003) · PubMed · Cited by 608
Oxidative stress injury in doxorubicin-induced cardiotoxicity
Songbo, M., Lang, H., Xinyong, C., Bin, X., Ping, Z., & Liang, S. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.02.013 · Cited by 566
The anthracyclines: will we ever find a better doxorubicin?
Weiss, R. B. (1992) · PubMed · Cited by 558
Oxidatively generated base damage to cellular DNA
Cadet, J., Douki, T., & Ravanat, J.-L. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.025 · Cited by 541
The extracellular release of HMGB1 during apoptotic cell death
Bell, C. W., Jiang, W., Reich, C. F., & Pisetsky, D. S. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00616.2005 · Cited by 538
Toxicity of Doxorubicin (Dox) to different experimental organ systems
Pugazhendhi, A., Edison, T. N. J. I., Velmurugan, B. K., Jacob, J. A., & Karuppusamy, I. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.03.023 · Cited by 452
The MRN complex in double‐strand break repair and telomere maintenance
Lamarche, B. J., Orazio, N. I., & Weitzman, M. D. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.07.029 · Cited by 446
New insights into the activities and toxicities of the old anticancer drug doxorubicin
van der Zanden, S. Y., Qiao, X., & Neefjes, J. (2021) · The FEBS Journal · doi:10.1111/febs.15583 · Cited by 410
PEGylation in anti-cancer therapy: An overview
Mishra, P., Nayak, B., & Dey, R. K. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2015.08.011 · Cited by 382
Zhao, L., & Zhang, B. (2017) · Scientific Reports · doi:10.1038/srep44735 · Cited by 375
Cappetta, D., De Angelis, A., Sapio, L., Prezioso, L., Illiano, M., Quaini, F., Rossi, F., Berrino, L., Naviglio, S., & Urbanek, K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1521020 · Cited by 350
Hallmarks of senescence and aging
Dodig, S., Čepelak, I., & Pavić, I. (2019) · Biochemia medica · doi:10.11613/bm.2019.030501 · Cited by 344
Oxidative DNA damage & repair: An introduction
Cadet, J., & Davies, K. J. A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.03.030 · Cited by 334
Wenningmann, N., Knapp, M., Ande, A., Vaidya, T. R., & Ait-Oudhia, S. (2019) · Molecular Pharmacology · doi:10.1124/mol.119.115725 · Cited by 334
Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
Mattarollo, S. R., Loi, S., Duret, H., Ma, Y., Zitvogel, L., & Smyth, M. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0753 · Cited by 333
Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines
Pilco-Ferreto, N., & Calaf, G. M. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3558 · Cited by 330
Kalyanaraman, B. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101394 · Cited by 326
Gorini, S., De Angelis, A., Berrino, L., Malara, N., Rosano, G., & Ferraro, E. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7582730 · Cited by 325
Lecona, E., & Fernandez-Capetillo, O. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0034-3 · Cited by 325
FORTINI, P., & DOGLIOTTI, E. (2007) · DNA Repair · doi:10.1016/j.dnarep.2006.10.008 · Cited by 318
Shafei, A., El-Bakly, W., Sobhy, A., Wagdy, O., Reda, A., Aboelenin, O., Marzouk, A., El Habak, K., Mostafa, R., Ali, M. A., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.059 · Cited by 318
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
Dallavalle, S., Dobričić, V., Lazzarato, L., Gazzano, E., Machuqueiro, M., Pajeva, I., Tsakovska, I., Zidar, N., & Fruttero, R. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100682 · Cited by 318
Kythreotou, A., Siddique, A., Mauri, F. A., Bower, M., & Pinato, D. J. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204853 · Cited by 317
Doxorubicin-DNA Adducts Induce a Non-Topoisomerase II–Mediated Form of Cell Death
Swift, L. P., Rephaeli, A., Nudelman, A., Phillips, D. R., & Cutts, S. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3410 · Cited by 314
DNA damage induced by endogenous aldehydes: Current state of knowledge
Voulgaridou, G.-P., Anestopoulos, I., Franco, R., Panayiotidis, M. I., & Pappa, A. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.03.006 · Cited by 304
Xue, C.-C., Li, M.-H., Zhao, Y., Zhou, J., Hu, Y., Cai, K.-Y., Zhao, Y., Yu, S.-H., & Luo, Z. (2020) · Science Advances · doi:10.1126/sciadv.aax1346 · Cited by 299
Kim, S.-Y., Kim, S.-J., Kim, B.-J., Rah, S.-Y., Chung, S. M., Im, M.-J., & Kim, U.-H. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.63 · Cited by 297
Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity
Aries, A., Paradis, P., Lefebvre, C., Schwartz, R. J., & Nemer, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401833101 · Cited by 296
The MRN complex: coordinating and mediating the response to broken chromosomes
van den Bosch, M., Bree, R. T., & Lowndes, N. F. (2003) · The EMBO Reports · doi:10.1038/sj.embor.embor925 · Cited by 289
Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches
Sheibani, M., Azizi, Y., Shayan, M., Nezamoleslami, S., Eslami, F., Farjoo, M. H., & Dehpour, A. R. (2022) · Cardiovascular Toxicology · doi:10.1007/s12012-022-09721-1 · Cited by 276
Gaillard, P. J., Appeldoorn, C. C. M., Dorland, R., van Kregten, J., Manca, F., Vugts, D. J., Windhorst, B., van Dongen, G. A. M. S., de Vries, H. E., Maussang, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0082331 · Cited by 273
Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis
Tsang, W. P., Chau, S. P. Y., Kong, S. K., Fung, K. P., & Kwok, T. T. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00566-6 · Cited by 272
New molecular and biochemical insights of doxorubicin-induced hepatotoxicity
Prasanna, P. L., Renu, K., & Valsala Gopalakrishnan, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117599 · Cited by 267
Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview
Kciuk, M., Marciniak, B., & Kontek, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144919 · Cited by 266
Self-citationMitochondrial Ceramide and the Induction of Apoptosis
Siskind, L. J. (2005) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-005-6567-7 · Cited by 253
Kurz, E. U., Douglas, P., & Lees-Miller, S. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406879200 · Cited by 250
Fournel, L., Wu, Z., Stadler, N., Damotte, D., Lococo, F., Boulle, G., Ségal-Bendirdjian, E., Bobbio, A., Icard, P., Trédaniel, J., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.08.005 · Cited by 249
Combined cytotoxic chemotherapy and immunotherapy of cancer: modern times
Bailly, C., Thuru, X., & Quesnel, B. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa002 · Cited by 249
Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview
Lang, D. K., Kaur, R., Arora, R., Saini, B., & Arora, S. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200705214917 · Cited by 246
Advances in Delivery Systems for Doxorubicin
Zhao, N., C Woodle, M., & Mixson, A. J. (2018) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000519 · Cited by 243
Sapra, P., & Allen, T. M. (2002) · PubMed · Cited by 242
Coordination of DNA single strand break repair
Abbotts, R., & Wilson, D. M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.039 · Cited by 240
Protein-associated DNA breaks in cells treated with adriamycin or ellipticine
Ross, W. E., Glaubiger, D. L., & Kohn, K. W. (1978) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(78)90059-x · Cited by 236
Hussain, Z., Khan, S., Imran, M., Sohail, M., Shah, S. W. A., & de Matas, M. (2019) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00631-4 · Cited by 220
Doxorubicin-induced persistent oxidative stress to cardiac myocytes
Zhou, S., Palmeira, C. M., & Wallace, K. B. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00329-0 · Cited by 219
Mechanisms and management of doxorubicin cardiotoxicity
Shi, Y., Moon, M., Dawood, S., McManus, B., & Liu, P. P. (2011) · Herz · doi:10.1007/s00059-011-3470-3 · Cited by 215
Ling, Y. H., el-Naggar, A. K., Priebe, W., & Perez-Soler, R. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09073-x · Cited by 213
To heat or not to heat: Challenges with clinical translation of thermosensitive liposomes
Dou, Y., Hynynen, K., & Allen, C. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.025 · Cited by 210
Cellular responses to reactive oxygen species-induced DNA damage and aging
Bertram, C., & Hass, R. (2008) · bchm · doi:10.1515/bc.2008.031 · Cited by 209
Kalivendi, S. V., Konorev, E. A., Cunningham, S., Vanamala, S. K., Kaji, E. H., Joseph, J., & Kalyanaraman, B. (2005) · Biochemical Journal · doi:10.1042/bj20050285 · Cited by 205
Mullen, T. D., & Obeid, L. M. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012800228661 · Cited by 204
Structure of the adriamycin-cardiolipin complex
Goormaghtigh, E., Huart, P., Praet, M., Brasseur, R., & Ruysschaert, J.-M. (1990) · Biophysical Chemistry · doi:10.1016/0301-4622(90)80012-v · Cited by 200
Lüpertz, R., Wätjen, W., Kahl, R., & Chovolou, Y. (2010) · Toxicology · doi:10.1016/j.tox.2010.03.012 · Cited by 197
Targeting ATR in DNA damage response and cancer therapeutics
Fokas, E., Prevo, R., Hammond, E. M., Brunner, T. B., McKenna, W. G., & Muschel, R. J. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.03.002 · Cited by 189
Zhang, Z., Zhang, H., Li, D., Zhou, X., Qin, Q., & Zhang, Q. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16574 · Cited by 188
Tran, L., Allen, C. T., Xiao, R., Moore, E., Davis, R., Park, S.-J., Spielbauer, K., Van Waes, C., & Schmitt, N. C. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0235 · Cited by 186
CD22: A Multifunctional Receptor That Regulates B Lymphocyte Survival and Signal Transduction
Tedder, T. F., Poe, J. C., & Haas, K. M. (2005) · Advances in Immunology · doi:10.1016/s0065-2776(05)88001-0 · Cited by 185
Black, M., Barsoum, I. B., Truesdell, P., Cotechini, T., Macdonald-Goodfellow, S. K., Petroff, M., Siemens, D. R., Koti, M., Craig, A. W. B., & Graham, C. H. (2016) · Oncotarget · doi:10.18632/oncotarget.7235 · Cited by 182
Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy
Batist, G., Barton, J., Chaikin, P., Swenson, C., & Welles, L. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.12.1739 · Cited by 179
Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells
Sliwinska, M. A., Mosieniak, G., Wolanin, K., Babik, A., Piwocka, K., Magalska, A., Szczepanowska, J., Fronk, J., & Sikora, E. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.04.011 · Cited by 178
Mammalian single-strand break repair: Mechanisms and links with chromatin
CALDECOTT, K. (2007) · DNA Repair · doi:10.1016/j.dnarep.2006.10.006 · Cited by 174
Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy
Zhong, Y.-J., Shao, L., & Li, Y. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1754 · Cited by 173
Advances in nano-delivery systems for doxorubicin: an updated insight
Kanwal, U., Bukhari, N. I., Ovais, M., Abass, N., Hussain, K., & Raza, A. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1380655 · Cited by 171
Focus on UV-Induced DNA Damage and Repair—Disease Relevance and Protective Strategies
Kciuk, M., Marciniak, B., Mojzych, M., & Kontek, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197264 · Cited by 168 · cited 7×
“Moreover, CHK2 phosphorylates TP53, a protein regarded as the guardian of the genome, which controls the expression of proapoptotic genes (including proapoptotic protein BAX) and inhibitors of antiapoptotic proteins (including phorbol-12-myristate-13-acetate-induced protein 1 (NOXA) and isoform 1 of Bcl-2-binding comp…”
BackgroundInfluentialSelf-citationEmami, F., Banstola, A., Vatanara, A., Lee, S., Kim, J. O., Jeong, J.-H., & Yook, S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01157 · Cited by 167
Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats
Rashid, S., Ali, N., Nafees, S., Ahmad, S. T., Arjumand, W., Hasan, S. K., & Sultana, S. (2012) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.759306 · Cited by 165
Doxorubicin Induced Nephrotoxicity: Protective Effect of Nicotinamide
Ayla, S., Seckin, I., Tanriverdi, G., Cengiz, M., Eser, M., Soner, B. C., & Oktem, G. (2011) · International Journal of Cell Biology · doi:10.1155/2011/390238 · Cited by 165
Batey, M. A., Zhao, Y., Kyle, S., Richardson, C., Slade, A., Martin, N. M. B., Lau, A., Newell, D. R., & Curtin, N. J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0707 · Cited by 164
Nanomaterials for Diagnosis and Treatment of Brain Cancer: Recent Updates
Mukhtar, M., Bilal, M., Rahdar, A., Barani, M., Arshad, R., Behl, T., Brisc, C., Banica, F., & Bungau, S. (2020) · Chemosensors · doi:10.3390/chemosensors8040117 · Cited by 164
Doxorubicin induces senescence and impairs function of human cardiac progenitor cells
Piegari, E., Angelis, A., Cappetta, D., Russo, R., Esposito, G., Costantino, S., Graiani, G., Frati, C., Prezioso, L., Berrino, L., et al. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0334-4 · Cited by 163
Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes
Gilliam, L. A. A., Moylan, J. S., Patterson, E. W., Smith, J. D., Wilson, A. S., Rabbani, Z., & Reid, M. B. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00217.2011 · Cited by 161
Spallarossa, P., Altieri, P., Aloi, C., Garibaldi, S., Barisione, C., Ghigliotti, G., Fugazza, G., Barsotti, A., & Brunelli, C. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00068.2009 · Cited by 160
DNA-PKcs: A Multi-Faceted Player in DNA Damage Response
Yue, X., Bai, C., Xie, D., Ma, T., & Zhou, P.-K. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.607428 · Cited by 160
Ibrahim, M., Abuwatfa, W. H., Awad, N. S., Sabouni, R., & Husseini, G. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020254 · Cited by 160
Defeo-Jones, D., Garsky, V. M., Wong, B. K., Feng, D.-M., Bolyar, T., Haskell, K., KIEFER, D. M., Leander, K. R., McAvoy, E., Lumma, P. K., et al. (2000) · Nature Medicine · doi:10.1038/81351 · Cited by 159
Cheng, W. W. K., & Allen, T. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.005 · Cited by 159
Liposomal doxorubicin as targeted delivery platform: Current trends in surface functionalization
Makwana, V., Karanjia, J., Haselhorst, T., Anoopkumar‐Dukie, S., & Rudrawar, S. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.120117 · Cited by 159
Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes
Lopez, M., Soler, F., Pascual-Figal, D. A., Fernández-Belda, F., & Lax, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172803 · Cited by 157
Sphingosine and ceramide signalling in apoptosis
Woodcock, J. M. (2006) · IUBMB Life · doi:10.1080/15216540600871118 · Cited by 154
Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity
Sishi, B., Loos, B., van Rooyen, J., & Engelbrecht, A. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.10.005 · Cited by 153
Anticancer metal drugs and immunogenic cell death
Terenzi, A., Pirker, C., Keppler, B. K., & Berger, W. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.06.021 · Cited by 151
Doi, T., Ishikawa, T., Okayama, T., Oka, K., Mizushima, K., Yasuda, T., Sakamoto, N., Katada, K., Kamada, K., Uchiyama, K., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5399 · Cited by 150
Immune Checkpoint PD‐1/PD‐L1: Is There Life Beyond Antibodies?
Konstantinidou, M., Zarganes‐Tzitzikas, T., Magiera‐Mularz, K., Holak, T. A., & Dömling, A. S. S. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201710407 · Cited by 147
Yang, S., Shim, M. K., Kim, W. J., Choi, J., Nam, G., Kim, J., Kim, J., Moon, Y., Kim, H. Y., Park, J., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120791 · Cited by 147
Tumor cell senescence response produces aggressive variants
Yang, L., Fang, J., & Chen, J. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.49 · Cited by 140
Bao, Y., Yin, M., Hu, X., Zhuang, X., Sun, Y., Guo, Y., Tan, S., & Zhang, Z. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.003 · Cited by 139
Doxorubicin-Loaded Nanoparticles: New Advances in Breast Cancer Therapy
Prados, J. C., Melguizo, C., Ortíz, R., Vélez, C., Alvarez, P. J., Arias, J. L., Ruiz, M. A., Gallardo, V., & Aránega, A. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012803529646 · Cited by 138
Mross, K. B., Niemann, B., Massing, U., Drevs, J., Unger, C., Bhamra, R. K., & Swenson, C. E. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0825-y · Cited by 137
Varela‐López, A., Battino, M. A., Navarro‐Hortal, M. D., Giampieri, F., Forbes-Hernández, T. Y., Romero‐Márquez, J. M., Collado, R., & Quiles, J. L. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110834 · Cited by 133
Doxorubicin Exerts Cytotoxic Effects through Cell Cycle Arrest and Fas-Mediated Cell Death
Kim, H., Lee, Y., & Kim, D. (2009) · Pharmacology · doi:10.1159/000245937 · Cited by 132
Ma, J., Wang, Y., Zheng, D., Meng, W., Xu, H., & Peng, T. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs309 · Cited by 132
Benzer, F., Kandemır, F. M., Küçükler, S., Çomaklı, S., & Çağlayan, C. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2017.1422766 · Cited by 128
Yu, P., Wang, H., Tian, M., Li, A.-X., Chen, X., Wang, X., Zhang, Y., & Cheng, Y. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0222-z · Cited by 127
Meng, L., Lin, H., Zhang, J., Lin, N., Sun, Z., Gao, F., Luo, H., Ni, T., Luo, W., Chi, J., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.08.009 · Cited by 126
Birngruber, T., Raml, R., Gladdines, W., Gatschelhofer, C., Gander, E., Ghosh, A., Altendorfer‐Kroath, T., Gaillard, P. J., Pieber, T. R., & Sinner, F. M. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23994 · Cited by 125
Ansari, L., Shiehzadeh, F., Taherzadeh, Z., et al. (2017) · Cancer Gene Therapy · doi:10.1038/cgt.2017.9 · Cited by 123
Doxorubicin Enhances Nucleosome Turnover around Promoters
Yang, F., Kemp, C. J., & Henikoff, S. (2013) · Current Biology · doi:10.1016/j.cub.2013.03.043 · Cited by 122
Liu, S., Chen, S., Yuan, W., Wang, H., Chen, K., Li, D., & Li, D. (2017) · Oncotarget · doi:10.18632/oncotarget.21914 · Cited by 121
Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents
Bojko, A., Czarnecka‐Herok, J., Charzyńska, A., Dąbrowski, M., & Sikora, E. (2019) · Cells · doi:10.3390/cells8121501 · Cited by 121
Hrelia, S., Fiorentini, D., Maraldi, T., Angeloni, C., Bordoni, A., Biagi, P. L., & Hakim, G. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00612-0 · Cited by 120
Sohail, M., Sun, Z., Li, Y., Gu, X., & Xu, H. Z. (2021) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2021.1991316 · Cited by 120
Lapatinib and doxorubicin enhance the S tat1‐dependent antitumor immune response
Hannesdóttir, L., Tymoszuk, P., Parajuli, N., Wasmer, M.-H., Philipp, S., Daschil, N., Datta, S., Koller, J., Tripp, C. H., Stoitzner, P., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201242505 · Cited by 115
Sapra, P., Moase, E. H., Ma, J., & Allen, T. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0041 · Cited by 114
Accelerated cardiomyocyte senescence contributes to late-onset doxorubicin-induced cardiotoxicity
Mitry, M. A., Laurent, D., Keith, B. L., Sira, E., Eisenberg, C. A., Eisenberg, L. M., Joshi, S. R., Gupte, S. A., & Edwards, J. G. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00073.2019 · Cited by 114
Induction of Pyroptosis: A Promising Strategy for Cancer Treatment
Wang, L., Qin, X., Liang, J., & Ge, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.635774 · Cited by 113
PARP1: Structural insights and pharmacological targets for inhibition
Spiegel, J. O., Houten, B. V., & Durrant, J. D. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103125 · Cited by 113
Benkafadar, N., François, F., Affortit, C., Casas, F., Ceccato, J.-C., Menardo, J., Venail, F., Malfroy-Camine, B., Puel, J., & Wang, J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1493-6 · Cited by 110
Zhao, T., Li, Y., Zhang, J., & Zhang, B. (2020) · Oncology Letters · doi:10.3892/ol.2020.11647 · Cited by 108
Cyclin-dependent kinases in DNA damage response
Kciuk, M., Gielecińska, A., Mujwar, S., Mojzych, M., & Kontek, R. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188716 · Cited by 108
Self-citationTangpong, J., Miriyala, S., Noel, T. J., Sinthupibulyakit, C., Jungsuwadee, P., & Clair, D. K. S. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.11.007 · Cited by 107
Karabicici, M., Alptekin, S., Karagonlar, Z. F., & Erdal, E. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12916 · Cited by 104
Mechanisms of doxorubicin-mediated reproductive toxicity – A review
Mohan, U. P., Pichiah, P. B. T., Iqbal, S. T. A., & Arunachalam, S. (2021) · Reproductive Toxicology · doi:10.1016/j.reprotox.2021.04.003 · Cited by 103
Albright, C. F., Graciani, N. R., Han, W., Yue, E. W., Stein, R. L., Lai, Z., Diamond, M. A., Dowling, R. L., Grimminger, L. C., Zhang, S., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0006 · Cited by 102
Paszko, E., & Senge, M. O. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803833362 · Cited by 96
Wang, Z., Wang, J., Xie, R., Liu, R., & Lu, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160511087 · Cited by 95
Luanpitpong, S., Pithi Chanvorachote, B., Nimmannit, U., Leonard, S. S., Stehlik, C., Wang, L., & Rojanasakul, Y. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.03.010 · Cited by 94
Lahoti, T. S., Patel, D., Thekkemadom, V., et al. (2012) · Current Neurovascular Research · doi:10.2174/156720212803530636 · Cited by 92
Guo, B., Tam, A., Santi, S. A., & Parissenti, A. M. (2016) · BMC Cancer · doi:10.1186/s12885-016-2790-3 · Cited by 90
Ock, C.-Y., Kim, S., Keam, B., Kim, S., Ahn, Y., Chung, E., Kim, J.-H., Kim, T. M., Kwon, S. K., Jeon, Y. K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18542 · Cited by 90
Yang, M., Lin, P., Liu, Y., Hsiao, H., Yang, W.-C., Hsu, J.-F., Hsu, C., & Lin, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037205 · Cited by 89
Park, H. J., Bae, J. S., Kim, K. M., Moon, Y. J., Park, S., Ha, S. H., Hussein, U. K., Zhang, Z., Park, H. S., Park, B., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0772-9 · Cited by 89
Alhowail, A. H., Bloemer, J., Majrashi, M., Pinky, P. D., Bhattacharya, S., Zhang, Y., Bhattacharya, D., Eggert, M., Woodie, L. N., Buabeid, M. A., et al. (2019) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2019.1600086 · Cited by 89
Coldwell, K. E., Cutts, S. M., Ognibene, T. J., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn439 · Cited by 87
Divergence to apoptosis from ROS induced cell cycle arrest: Effect of cadmium
Chatterjee, S., Kundu, S., Sengupta, S., & Bhattacharyya, A. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.12.011 · Cited by 87
Liu, X., Guo, C., Tou, F., Wen, X., Kuang, Y., Zhu, Q., & Hu, H. (2019) · International Journal of Cancer · doi:10.1002/ijc.32744 · Cited by 87
Transcriptomic profiling reveals p53 as a key regulator of doxorubicin-induced cardiotoxicity
McSweeney, K. M., Bozza, W. P., Alterovitz, W.-L., & Zhang, B. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0182-6 · Cited by 86
Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic
Fraguas‐Sánchez, A. I., Lozza, I., & Torres‐Suárez, A. I. (2022) · Cancers · doi:10.3390/cancers14051198 · Cited by 84
Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation
Forrest, R. A., Swift, L. P., Rephaeli, A., Nudelman, A., Kimura, K., Phillips, D. R., & Cutts, S. M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.02.026 · Cited by 83
Montalvo, R. N., Doerr, V., Min, K., Szeto, H. H., & Smuder, A. J. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00299.2019 · Cited by 83
ROS-induced cell cycle arrest as a mechanism of resistance in polyaneuploid cancer cells (PACCs)
Kuczler, M. D., Olseen, A. M., Pienta, K. J., & Amend, S. R. (2021) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2021.05.002 · Cited by 83
Iwai, T., Sugimoto, M., Wakita, D., Yorozu, K., Kurasawa, M., & Yamamoto, K. (2018) · Oncotarget · doi:10.18632/oncotarget.25830 · Cited by 82
Wang, T., Tang, J., Yang, H., Yin, R., Zhang, J., Zhou, Q., Liu, Z., Cao, L., Li, L., Huang, Y., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.2253 · Cited by 81
Qin, X., Liu, C., Zhou, Y., & Wang, G. (2010) · PubMed · Cited by 79
MRN complex is an essential effector of DNA damage repair
Qiu, S., & Huang, J. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000289 · Cited by 77
DNA-PKcs: A Targetable Protumorigenic Protein Kinase
Dylgjeri, E., & Knudsen, K. E. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1756 · Cited by 76
Filippova, M., Filippov, V. A., Williams, V. M., Zhang, K., Kokoza, A., Bashkirova, S., & Duerksen-Hughes, P. J. (2014) · BioMed Research International · doi:10.1155/2014/574659 · Cited by 75
Luo, X., Evrovsky, Y., Cole, D. E. C., Trines, J., Benson, L. N., & Lehotay, D. C. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(96)00068-3 · Cited by 73
Antonucci, S., Sante, M. D., Tonolo, F., Pontarollo, L., Scalcon, V., Alánová, P., Menabò, R., Carpi, A., Bindoli, A., Rigobello, M. P., et al. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7929 · Cited by 72
Neuroprotective Potential of Berberine Against Doxorubicin-Induced Toxicity in Rat’s Brain
Fouad, G. I., & Ahmed, K. A. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03428-5 · Cited by 71
Kawano, M., Tanaka, K., Itonaga, I., Iwasaki, T., Miyazaki, M., Ikeda, S., & Tsumura, H. (2016) · Oncology Letters · doi:10.3892/ol.2016.4175 · Cited by 69
Calreticulin, a therapeutic target?
Eggleton, P., Bremer, E., Dudek, E., & Michalak, M. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1164695 · Cited by 69
Luo, R., Li, Y., He, M., Zhang, H., Yuan, H., Johnson, M. T., Palmisano, M., Zhou, S. Y., & Sun, D. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.002 · Cited by 69
Magnetic tweezers measurements of the nanomechanical properties of DNA in the presence of drugs
Salerno, D., Brogioli, D., Cassina, V., Turchi, D. M., Beretta, G. L., Seruggia, D., Ziano, R., Zunino, F., & Mantegazza, F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq597 · Cited by 68
Mei, C., Lei, L., Tan, L., Xu, X., He, B., Luo, C., Yin, J., Li, X., Zhang, W., Zhou, H.-H., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109875 · Cited by 68
Gilad, Y., Eliaz, Y., Yu, Y., Han, S. J., O’Malley, B. W., & Lonard, D. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-51537-7 · Cited by 67
Ferroptosis: A New Road towards Cancer Management
Bano, I., Horký, P., Abbas, S. Q., Majid, M., Bilal, A. H. M., Ali, F., Behl, T., Hassan, S. S. U., & BUNGAU, S. G. (2022) · Molecules · doi:10.3390/molecules27072129 · Cited by 67
Miguel, R. D. A., Hirata, A. S., Jimenez, P. C., Lopes, L. B., & Costa-Lotufo, L. V. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081722 · Cited by 66
Giuliani, F. C., & Kaplan, N. O. (1980) · PubMed · Cited by 65
Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity
Mastria, E. M., Cai, L. Y., Kan, M. J., Li, X., Schaal, J. L., Fiering, S., Gunn, M. D., Dewhirst, M. W., Nair, S. K., & Chilkoti, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.021 · Cited by 65
BURADE, V. S., Bhowmick, S., Maiti, K., Zalawadia, R., Ruan, H. H., & Thennati, R. (2017) · BMC Cancer · doi:10.1186/s12885-017-3377-3 · Cited by 64
DNA-protein crosslink formation by endogenous aldehydes and AP sites
Nakamura, J., & Nakamura, M. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102806 · Cited by 62
DENR controls JAK2 translation to induce PD-L1 expression for tumor immune evasion
Chen, B., Hu, J., Hu, X., Chen, H., Bao, R., Zhou, Y., Ye, Y., Zhan, M., Cai, W., Li, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29754-y · Cited by 62
Bientinesi, E., Lulli, M., Becatti, M., Ristori, S., Margheri, F., & Monti, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111689 · Cited by 61
Surprising roles of electrostatic interactions in DNA–ligand complexes
Howerton, S. B., Nagpal, A., & Williams, L. D. (2003) · Biopolymers · doi:10.1002/bip.10319 · Cited by 61
HMGB1 modulates the balance between senescence and apoptosis in response to genotoxic stress
Lee, J., Park, I. H., Rhee, W. J., Kim, H. S., & Shin, J. (2019) · The FASEB Journal · doi:10.1096/fj.201900288r · Cited by 60
Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies
Wang, W., Zhang, L., & Sun, Z. (2022) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0049 · Cited by 60
Aydınlık, Ş., Erkısa, M., Cevatemre, B., Sarımahmut, M., Dere, E., Arı, F., & Ulukaya, E. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.11.013 · Cited by 59
Yang, Y., Zuo, S., Li, L., Kuang, X., Li, J., Sun, B., Wang, S., He, Z., & Sun, J. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2021.05.001 · Cited by 59
Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy
Wu, X., Li, Y., Liu, X., Chen, C., Harrington, S. M., Cao, S., Xie, T., Pham, T. T., Mansfield, A. S., Yan, Y., et al. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e01039 · Cited by 57
Tsai, T., Lin, J., Lin, Y., Chou, K., Chen, H., Ho, C., Chen, P., & Hwang, T. I. (2019) · Bioscience Reports · doi:10.1042/bsr20190362 · Cited by 57
Doxorubicin loaded ferritin nanoparticles for ferroptosis enhanced targeted killing of cancer cells
Yang, R., Li, Y., Wang, X., Yan, J., Pan, D., Xu, Y., Wang, L., & Yang, M. (2019) · RSC Advances · doi:10.1039/c9ra04478g · Cited by 57
Merino, M., Lozano, T., Casares, N., Lana, H., Trocóniz, I. F., ten Hagen, T. L. M., Kochan, G. T., Berraondo, P., Zalba, S., & Garrido, M. J. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00846-z · Cited by 57
Reactive Oxygen Species Detection in Senescent Cells
Victorelli, S. G., & Passos, J. F. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8931-7_3 · Cited by 55
Hu, X., & Zhang, H. (2019) · Medical Science Monitor · doi:10.12659/msm.914295 · Cited by 55
Gajewski, E., Gaur, S., Akman, S. A., Matsumoto, L., van Balgooy, J. N. A., & Doroshow, J. H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.03.022 · Cited by 54
Doroshow, J. H., Synold, T. W., Somlo, G., Akman, S. A., & Gajewski, E. (2001) · Blood · doi:10.1182/blood.v97.9.2839 · Cited by 52
Elfadadny, A., Ragab, R. F., Hamada, R., Jaouni, S. K. A., Fu, J., Mousa, S. A., & El‐Far, A. H. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116405 · Cited by 52
During apoptosis HMGB1 is translocated into apoptotic cell-derived membraneous vesicles
Schiller, M. R., Heyder, P., Ziegler, S., Nießen, A., Claßen, L., Lauffer, A. M., & Lorenz, H. (2012) · Autoimmunity · doi:10.3109/08916934.2012.750302 · Cited by 50
Metadata
- Authors
- Kciuk, M., Gielecińska, A., Mujwar, S., Kołat, D., Kałuzińska-Kołat, Ż., Celik, I., & Kontek, R.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2023-02-19
- Volume
- 12
- Issue
- 4
- Pages
- 659
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W4321372972
- Cited by
- 810
- References
- 253
- FWCI
- 513.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.